ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Co-stimulation"

  • 2015 American Transplant Congress

    In Vitro Evidence That CTLA4Ig Attenuates Recall Alloantibody Responses

    I. Kim,1 G. Wu,1 N.-N. Chai,1 S. Jordan,2 A. Klein.1

    1Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA; 2Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.

    Background: CTLA4Ig is an agonist that blocks CD28-B7 costimulation, downregulating T cell immunity, but also appears to negate T cell-dependent B cell activation, thus inhibiting…
  • 2015 American Transplant Congress

    Anti-BTLA Antibody (6B2) Induced Prolongation of Fully MHC-Mismatched Murine Cardiac Allograft and Generation of Foxp3+ Regulatory T Cells

    M. Uchiyama,1,2,3 E. Yin,3,4 X. Jin,3,5 T. Shimokawa,1 H. Yagita,2 M. Niimi.3

    1Cardiovascular Surgery, Teikyo University, Tokyo, Japan; 2Immunology, Juntendo University Hospital, Tokyo, Japan; 3Surgery, Teikyo University, Tokyo, Japan; 4Cardiovascular Surgery, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; 5Cardiovascular and Thoracic Surgery, The 4th Affiliated Hospital of Harbin Medical University, Harbin, China.

    Background: The co-inhibitory receptor B and T lymphocyte attenuator (BTLA; CD272) has been implicated in the regulation of autoimmune and may potentially play an important…
  • 2015 American Transplant Congress

    Desensitization With Costimulation Blockade and Proteasome Inhibition in a Non-Human Primate Model of Kidney Transplantation

    C. Burghuber,1,2 J. Kwun,1 E. Page,1 A. Gibby,1 F. Leopardi,3 A. Farris,1 N. Iwakoshi,1 S. Knechtle.1,3

    1Emory Translant Center, Emory University, Atlanta, GA; 2Medical University Vienna, Vienna, Austria; 3Duke University, Durham, NC.

    [Background] Sensitization is a growing problem on the kidney waiting list. Alloantibody can significantly deteriorate graft survival. Currently used desensitization strategies are time-consuming, expensive and…
  • 2015 American Transplant Congress

    Blocking CD4 T Cell Helper Functions Improves Efficacy of ATG Treatment in Sensitized Transplant Recipients

    K. Ayasoufi, X. Wang, H. Yu, V. Gorbacheva, F. Ran, R. Fairchild, A. Valujskikh.

    Immunology, Cleveland Clinic, Cleveland, OH.

    Antibody mediated lymphocyte depletion is used in clinical transplantation to improve graft function. While the presence of donor-reactive memory T cells is the primary rationale…
  • 2015 American Transplant Congress

    Indefinite Survival of Fully MHC-Mismatched Murine Cardiac Allografts by Combination of Anti-BTLA mAb (6B2) and Anti-PD-1 mAb (PIM-2)

    E. Yin,1,2 M. Uchiyama,1,3,4 X. Jin,1,5 T. Shimokawa,3 H. Yagita,4 M. Niimi.1

    1Department of Surgery, Teikyo University, Tokyo, Japan; 2Department of Cardiovascular Surgery, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; 3Department of Cardiovascular Surgery, Teikyo University, Tokyo, Japan; 4Department of Immunology, Juntendo University Hospital, Tokyo, Japan; 5Department of Cardiovascular and Thoracic Surgery, The 4th Affiliated Hospital of Harbin Medical University, Harbin, China.

    Background: The co-inhibitory receptor B and T lymphocyte attenuator (BTLA) and Programmed death (PD)-1 had been suggested to have immunomodulatory activity. This study investigated the…
  • 2015 American Transplant Congress

    Galectin-9 Protects Mouse Liver Transplants Against Ischemia-Reperfusion Injury

    H. Ji, Y. Liu, Y. Zhang, X. Shen, F. Gao, R. Busuttil, J. Kupiec-Weglinski.

    Dept of Surgery, Dumont-UCLA Liver Transplant Center, Los Angeles, CA.

    Background:Although Galecin 9 (Gal-9) negatively regulates Th1-type alloimmunity by binding to T-cell Immunoglobulin Mucin-3 (TIM-3) on activated Th1 cells, its role in liver ischemia-reperfusion injury…
  • 2015 American Transplant Congress

    Vascularized Bone Marrow Plays a Critical Role in Inducing Tolerance of Osteomyocutaneous Allografts

    C.-H. Lin,1 M. Anggelia,1 Y.-L. Wang,1 H.-Y. Cheng,1 W. Lee,2 G. Brandacher.2

    1Center for Vascularized Composite Allotransplantation, Chang Gung Memorial Hospital, Taipei, Taiwan; 2Department of Plastic and Reconstructive Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

    Background: Vascularized composite allograft (VCA) that includes medullary bone may provide proposed benefits ofvascularized bone marrow transplantation (VBMT), such as a continuous supply of donor…
  • 2015 American Transplant Congress

    2B4 Expression on Human CD4+ Memory T Cells Is Associated With Functional Impairment

    C. Chen, S. Laurie, J. Lyons, C. Coopersmith, M. Ford.

    Emory Transplant Center, Emory University, Atlata, GA.

    The SLAM family receptor 2B4 is expressed primarily on NK cells and memory CD8+ T cells. In prior studies, we found that 2B4 was upregulated…
  • 2015 American Transplant Congress

    VLA-4 Blockade Inhibits Endogenous Memory CD8 T Cell-Mediated Rejection of Cardiac Allografts

    S. Iida,1 C. Su,1 T. Abe,1 K. Tanabe,2 R. Fairchild.1

    1Immunology, Cleveland Clinic, Cleveland, OH; 2Urology, Tokyo Women's Medical University, Tokyo, Japan.

    Endogenous memory CD8 T cells infiltrate cardiac allografts within 24 hours of reperfusion and are activated to proliferate and produce IFN-γ in response to donor…
  • 2015 American Transplant Congress

    Bridging Therapy With Belatacept in High MELD Liver Transplant Recipients

    T. Sparkes,1 B. Masters,1 S. Hanish,2 D. Potosky,2 W. Hutson,2 J. LaMattina,2 R. Barth.2

    1University of Maryland Medical Center, Baltimore; 2University of Maryland School of Medicine, Baltimore.

    Background: Poor outcomes of high-MELD liver transplant recipients are driven by multisystem organ dysfunction. Renal failure post-transplant has been associated with mortality of greater than…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences